Echo Street Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
FP
TP
Echo Street Capital Management's MRNA Position: Q4 2022 in Review
Echo Street Capital Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 2,786 shares — an estimated $329K sold.
Echo Street Capital Management first reported a position in MRNA in Q1 2021 and held it in 6 quarters. The position peaked at $1.03M in Q4 2021. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.
- Echo Street Capital Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
- Echo Street Capital Management sold 2,786 Moderna shares in Q4 2022, an estimated $329K.
- Echo Street Capital Management first reported a position in Moderna in Q1 2021 and held it in 6 quarters.
- Echo Street Capital Management's Moderna position peaked at $1.03M in Q4 2021.
- 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.
Based on Echo Street Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.